DK1020454T3 - Polymorfe former af 2-(3-cyano-4-isobutyloxyphenyl)-4-mehyl-5-thiazol-carboxylsyre og fremgangsmåde til fremstilling deraf - Google Patents

Polymorfe former af 2-(3-cyano-4-isobutyloxyphenyl)-4-mehyl-5-thiazol-carboxylsyre og fremgangsmåde til fremstilling deraf

Info

Publication number: DK1020454T3
Authority: DK; Denmark
Prior art keywords: isobutyloxyphenyl; cyano; methyl; polymorphs; thiazole
Prior art date: 1998-06-19

Application number

DK99957054T

Other languages

English (en)

Other versions

DK1020454T4 (da

Inventor

Koichi Matsumoto

Kenzo Watanabe

Toshiyuki Hiramatsu

Mitsutaka Kitamura

Original Assignee

Teijin Pharma Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-19

Filing date

1999-06-18

Publication date

2010-01-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=15953825&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1020454(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-06-18 Application filed by Teijin Pharma Ltd filed Critical Teijin Pharma Ltd

2010-01-04 Application granted granted Critical

2010-01-04 Publication of DK1020454T3 publication Critical patent/DK1020454T3/da

2013-11-25 Publication of DK1020454T4 publication Critical patent/DK1020454T4/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Physical Education & Sports Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Thiazole And Isothizaole Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

DK99957054.2T 1998-06-19 1999-06-18 Polymorfe former af 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazol-carboxylsyre og fremgangsmåde til fremstilling deraf DK1020454T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP17307998		1998-06-19
PCT/JP1999/003258 WO1999065885A1 (en)	1998-06-19	1999-06-18	Polymorphic modifications of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazole-carboxylic acid and processes for the preparation thereof

Publications (2)

Publication Number	Publication Date
DK1020454T3 true DK1020454T3 (da)	2010-01-04
DK1020454T4 DK1020454T4 (da)	2013-11-25

Family

ID=15953825

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
DK08005933.0T DK1956014T3 (da)	1998-06-19	1999-06-18	Polymorfer af 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolcarboxylsyre og fremgangsmåde til fremstilling deraf
DK99957054.2T DK1020454T4 (da)	1998-06-19	1999-06-18	Polymorfe former af 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazol-carboxylsyre og fremgangsmåde til fremstilling deraf
DK08005934.8T DK1956015T4 (da)	1998-06-19	1999-06-18	Polymorf af 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolcarboxylsyre og fremgangsmåde til fremstilling deraf

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK08005933.0T DK1956014T3 (da)	1998-06-19	1999-06-18	Polymorfer af 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolcarboxylsyre og fremgangsmåde til fremstilling deraf

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK08005934.8T DK1956015T4 (da)	1998-06-19	1999-06-18	Polymorf af 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolcarboxylsyre og fremgangsmåde til fremstilling deraf

Country Status (39)

Country	Link
US (1)	US6225474B1 (da)
EP (4)	EP1956014B1 (da)
JP (1)	JP3547707B2 (da)
KR (1)	KR100511183B1 (da)
CN (3)	CN102020617B (da)
AT (2)	ATE522512T2 (da)
AU (1)	AU748026B2 (da)
BE (1)	BE2010C024I2 (da)
BG (1)	BG64734B1 (da)
BR (1)	BR9906539A (da)
CA (2)	CA2566652C (da)
CY (3)	CY1109720T1 (da)
CZ (1)	CZ298170B6 (da)
DE (2)	DE69941672D1 (da)
DK (3)	DK1956014T3 (da)
ES (3)	ES2718467T3 (da)
FR (1)	FR10C0022I2 (da)
GT (1)	GT199900216A (da)
HK (2)	HK1029788A1 (da)
HR (2)	HRP20000092C1 (da)
HU (2)	HU229405B1 (da)
ID (1)	ID25775A (da)
IL (1)	IL134594A (da)
IN (1)	IN191537B (da)
IS (4)	IS9020A (da)
LT (1)	LT1956014T (da)
LU (1)	LU91682I2 (da)
NO (1)	NO321308B1 (da)
NZ (1)	NZ503326A (da)
PL (1)	PL200710B1 (da)
PT (3)	PT1020454E (da)
RU (1)	RU2198169C3 (da)
SI (3)	SI1956014T1 (da)
SK (2)	SK287928B6 (da)
TR (1)	TR200000458T1 (da)
TW (1)	TWI248439B (da)
UA (1)	UA57611C2 (da)
WO (1)	WO1999065885A1 (da)
ZA (1)	ZA200000737B (da)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6225474B1 (en)	1998-06-19	2001-05-01	Teijin Limited	Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
JP2005502628A (ja) *	2001-07-10	2005-01-27	ファルマシア・アンド・アップジョン・カンパニー	結晶性チアジンオキサゾリジノン
EA006445B9 (ru) *	2001-08-15	2017-02-28	Фармация Энд Апджон Компани	Кристаллы, содержащие соль яблочной кислоты n-[2-(диэтиламино)этил]-5-[(5-фторо-2-оксо-1,2-дигидро-3h-индол-3-илиден)метил]-2,4-диметил-1h-пиррол-3-карбоксамида, способы их получения и их композиции
ES2412306T3 (es) *	2002-01-09	2013-07-11	Emisphere Technologies, Inc.	Polimorfos de 4-((4-cloro-2-hidroxibenzoil)amino)butanoato de sodio
JP2003261548A (ja) *	2002-03-07	2003-09-19	Teijin Ltd	２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法
DK1488790T3 (da) *	2002-03-28	2014-10-13	Teijin Pharma Ltd	Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat
JP2008545627A (ja) *	2005-05-09	2008-12-18	タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド	腎結石症を治療する方法
CN100430055C (zh) *	2005-11-11	2008-11-05	天津泰普药品科技发展有限公司	2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸和聚乙烯吡咯烷酮玻璃态固溶体及其制备方法
EP2039691B1 (en) *	2006-06-23	2013-09-18	Teijin Pharma Limited	Process for production of a polymorph of 2-(3-cyano-4- isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid
CN101139325B (zh) *	2006-09-07	2010-05-12	上海医药工业研究院	2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
CN101812035B (zh) *	2006-09-07	2012-03-21	上海医药工业研究院	2-(3-氰基-4-异丁氧基苯基)-4-甲基-5-噻唑甲酸晶型及其制备方法
KR20160031040A (ko) *	2006-11-13	2016-03-21	다케다 파마슈티칼스 유에스에이, 인코포레이티드	크산틴 옥시도리덕타아제 억제제를 사용하여 신장 기능을 보존하는 방법
US20090124623A1 (en) *	2006-11-13	2009-05-14	Christopher Lademacher	Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
CN1970547B (zh) *	2006-12-07	2011-04-06	重庆医药工业研究院有限责任公司	非布司他的晶型及其制备方法
CN102093309B (zh) *	2006-12-07	2012-07-04	重庆医药工业研究院有限责任公司	非布司他的晶型及其制备方法
CN102093308B (zh) *	2006-12-07	2012-08-29	重庆医药工业研究院有限责任公司	非布司他的晶型及其制备方法
EP2120956A4 (en) *	2007-01-19	2010-01-20	Takeda Pharmaceuticals North A	METHODS FOR PREVENTING OR REDUCING THE NUMBER OF DROUGHT ERYTHEMES USING XANTHINE OXYDOREDUCTASE INHIBITORS AND INFLAMMATORY AGENTS
CN101412700B (zh) *	2007-10-19	2011-06-08	上海医药工业研究院	非布司他的晶型及其制备方法
CN101386605B (zh) *	2008-10-23	2010-09-08	中国科学院上海药物研究所	非布司他新型晶体及其制备方法
CN101759656B (zh) *	2008-12-12	2013-04-03	重庆医药工业研究院有限责任公司	非布司他新晶型及其制备方法
CN101768150B (zh) *	2009-01-05	2014-08-06	常州市第四制药厂有限公司	2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
US20100311756A1 (en) *	2009-01-22	2010-12-09	Takeda Pharmaceuticals North America, Inc.	Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
CN101891702B (zh) *	2009-05-22	2012-07-04	重庆圣华曦药业股份有限公司	非布司他的晶体、制备方法及在药物中的应用
WO2010144685A1 (en)	2009-06-10	2010-12-16	Teva Pharmaceutical Industries Ltd.	Crystalline forms of febuxostat
JP5519201B2 (ja) *	2009-07-15	2014-06-11	光孝北村	２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法
JP5654462B2 (ja) *	2009-07-15	2015-01-14	帝人ファーマ株式会社	貧溶媒添加法による２−（３−シアノ−４−イソブチルオキシフェニル）−４−メチル−５−チアゾールカルボン酸の結晶多形体の製造方法
CN103936689B (zh) *	2009-07-17	2016-08-17	北京利乐生制药科技有限公司	2-[3-氰基-4-异丁氧基苯基]-4-甲基噻唑-5-甲酸晶型及其制备方法
WO2011080651A2 (en)	2009-12-31	2011-07-07	Ranbaxy Laboratories Limited	Polymorphic forms of febuxostat
US20130190366A1 (en)	2010-02-19	2013-07-25	Cadila Healthcare Limited	Substantially pure salts of febuxostat and processes for preparation thereof
CA2792036A1 (en)	2010-03-04	2011-09-09	Ranbaxy Laboratories Limited	Polymorph of 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylic acid
CN101824005B (zh) *	2010-04-27	2012-06-27	上海凯米侬医药科技有限公司	一种非布索坦的晶型q及其制备方法
WO2011134101A1 (zh) *	2010-04-27	2011-11-03	上海凯米侬医药科技有限公司	一种非布索坦的新晶型n及其制备方法
US8969582B2 (en)	2010-04-29	2015-03-03	Dr. Reddy's Laboratories Ltd.	Preparation of febuxostat
IT1400310B1 (it)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e statine e loro uso.
IT1400609B1 (it)	2010-05-10	2013-06-14	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e metformina e loro uso.
IT1400311B1 (it)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e antagonisti del recettore dell'angiotensina ii e loro uso.
IT1400309B1 (it)	2010-05-10	2013-05-24	Menarini Int Operations Lu Sa	Associazione di inibitori della xantina ossidasi e calcio antagonisti e loro uso.
EP2399911B1 (en)	2010-06-25	2015-08-19	Sandoz Ag	Polymorphs of Febuxostat
TW201217347A (en)	2010-07-13	2012-05-01	Interquim Sa	Process for preparing the crystalline form a of febuxostat
WO2012020272A2 (en)	2010-08-13	2012-02-16	EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság	New salts, polymorphs and solvates of a pharmaceutical active ingredient
KR101797936B1 (ko)	2010-09-10	2017-11-15	다케다 파마슈티칼스 유에스에이, 인코포레이티드	테오필린과 페북소스타트의 병용 치료 방법
EP2619191A4 (en) *	2010-09-24	2014-03-26	Hetero Research Foundation	NEW POLYMORPHS OF FEBUXOSTAT
CN102442971B (zh) *	2010-10-13	2014-06-18	欣凯医药化工中间体（上海）有限公司	非布司他的晶型及其制备方法
WO2012048861A1 (en)	2010-10-14	2012-04-19	Gador S.A.	A novel febuxostat crystalline form and the process for the preparation thereof
WO2012056442A1 (en) *	2010-10-28	2012-05-03	Mapi Pharma Holdings (Cyprus) Limited	Polymorphs of febuxostat
TWI520732B (zh) *	2011-01-18	2016-02-11	輝瑞有限公司	固體分子分散液
CN102127033A (zh) *	2011-01-21	2011-07-20	北京虹湾医药技术有限公司	非布索坦晶型及其工业化制备方法
EP2502920A1 (en)	2011-03-25	2012-09-26	Sandoz Ag	Crystallization process of Febuxostat from A
WO2012131590A1 (en)	2011-03-31	2012-10-04	Sandoz Ag	An improved process for preparation of febuxostat and its polymorphic crystalline form c thereof
WO2012140632A1 (en)	2011-04-15	2012-10-18	Ranbaxy Laboratories Limited	Febuxostat solid dispersion
WO2012153313A1 (en)	2011-05-11	2012-11-15	Ranbaxy Laboratories Limited	Pharmaceutical composition of febuxostat
EP2718272A2 (en) *	2011-06-06	2014-04-16	Hetero Research Foundation	Process for febuxostat
WO2012172461A1 (en)	2011-06-13	2012-12-20	Ranbaxy Laboratories Limited	Pharmaceutical compositions of febuxostat
AU2012342011A1 (en)	2011-11-15	2014-06-05	Mylan Laboratories Ltd	Process for the preparation of Febuxostat polymorphs
WO2013088449A1 (en)	2011-12-16	2013-06-20	Natco Pharma Limited	Stable crystal form of febuxostat and process for the preparation thereof
EP2925306A1 (en)	2012-07-12	2015-10-07	Alembic Pharmaceuticals Limited	Pharmaceutical composition of febuxostat
EP2692342A1 (en)	2012-07-30	2014-02-05	Interquim, S.A.	Process for the preparation of pharmaceutical compositions comprising febuxostat in the form of tablets
WO2014057461A1 (en)	2012-10-11	2014-04-17	Ranbaxy Laboratories Limited	Process for the preparation of crystalline form g of febuxostat
CN103936688A (zh) *	2013-01-21	2014-07-23	上海华拓医药科技发展股份有限公司	2-(3-氰基-4-(2-甲基丙氧基)苯基)-4-甲基-5-噻唑甲酸a晶的制备方法
NO2980085T3 (da) *	2013-03-29	2018-08-11
CN103396378B (zh) *	2013-07-29	2015-06-10	杭州朱养心药业有限公司	非布司他结晶
CN103588724B (zh) *	2013-09-10	2015-05-20	杭州华东医药集团新药研究院有限公司	一种非布司他晶型a及其制备方法
RU2016119523A (ru) *	2013-10-22	2017-11-28	Ниппон Кемифар Ко., Лтд.	Мелкие кристаллы 2-[3-циано-4-(2-метилпропокси)фенил]-4-метилтиазол-5-карбоновой кислоты, продукт их тонкого измельчения и содержащие их твердые препараты
EP2881116A1 (en)	2013-12-05	2015-06-10	Ranbaxy Laboratories Limited	Febuxostat composition
EP2902016A1 (en)	2014-01-30	2015-08-05	Alfred E. Tiefenbacher (GmbH & Co. KG)	Febuxostat tablet
CN103739568B (zh) *	2014-02-07	2015-09-16	浙江普洛康裕制药有限公司	2-(3-氰基-4-异丁氧基苯基)-4-甲基噻唑-5-甲酸a晶型的制备方法
BR112017001657B1 (pt)	2014-07-30	2023-01-17	Teijin Pharma Limited	Cristal, composto, composição farmacêutica, inibidor de xantina oxidase, agente terapêutico ou profilático para uma ou mais doenças, e, método de produção da forma de um cristal.
EP3002006A1 (en)	2014-10-01	2016-04-06	Bluepharma - Industria Farmacêutica, S.A.	Pharmaceutical composition capable for the incorporation Febuxostat in the crystalline modifications F10, II, G and A
CZ27857U1 (cs)	2014-12-12	2015-02-23	Zentiva, K.S.	Formulace obsahující tuhý roztok febuxostatu
JP2016150917A (ja) *	2015-02-17	2016-08-22	株式会社トクヤマ	バルサルタンの結晶の製造方法
JP7164926B2 (ja) *	2015-04-22	2022-11-02	日本ケミファ株式会社	２－［３－シアノ－４－（２－メチルプロポキシ）フェニル］－４－メチルチアゾール－５－カルボン酸の結晶、その製造方法、及びそれらの利用
EP3153158A1 (de)	2015-10-09	2017-04-12	Stada Arzneimittel Ag	Orale febuxostat-tablette
CN107540630A (zh) *	2016-06-29	2018-01-05	康普药业股份有限公司	一种非布司他化合物及制备方法
GR1009119B (el)	2016-06-30	2017-09-18	"Φαρματεν Α.Β.Ε.Ε."	Φαρμακευτικο σκευασμα περιεχον ενα μη πουρινικο επιλεκτικο αναστολεα της οξειδασης της ξανθινης και μεθοδος παρασκευης αυτου
KR20180013563A (ko) *	2016-07-29	2018-02-07	한미정밀화학주식회사	고순도 결정형 페북소스타트의 개선된 제조 방법
CN106565627B (zh) *	2016-10-10	2020-01-10	扬子江药业集团有限公司	一种非布司他药用晶型的制备方法
GR1009659B (el)	2018-09-07	2019-11-28	Φαρματεν Α.Β.Ε.Ε.	Φαρμακευτικο σκευασμα που περιλαμβανει ενα συμπλοκο αλατος της φεβουξοστατης με οξειδιο του μαγνησιου και μεθοδος για την παρασκευη αυτου
WO2020067275A1 (ja) *	2018-09-28	2020-04-02	株式会社カネカ	安定性に優れた還元型補酵素ｑ１０結晶の製造方法
CN112390766B (zh) *	2019-08-13	2022-09-06	浙江天宇药业股份有限公司	一种非布司他a晶型的制备方法
CN111004191A (zh) *	2019-10-24	2020-04-14	武汉光谷亚太医药研究院有限公司	一种大粒径非布司他a晶的制备方法
JP7506475B2 (ja) *	2019-12-26	2024-06-26	東和薬品株式会社	フェブキソスタット製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8506572D0 (en) †	1985-03-14	1985-04-17	Appointrose Ltd	Fire-resistant enclosures
ATE72244T1 (de)	1986-03-21	1992-02-15	Heumann Pharma Gmbh & Co	Kristalline, wasserfreie sigma -form von 2-(4-(2furoyl-(2-piperazin)-1-yl>-4-amino-6,7- dimethoxychinazolinhydrochlorid und verfahren zu ihrer herstellung.
US5015646A (en)	1987-08-28	1991-05-14	Bristol-Myers Squibb Co.	Pharmaceutically useful polymorphic modification of buspirone
ATE142494T1 (de)	1990-11-30	1996-09-15	Teijin Ltd	2-arylthiazolderivat sowie dieses enthaltendes arzneimittel
JP2706037B2 (ja) *	1993-04-13	1998-01-28	帝人株式会社	シアノ化合物およびその製造方法
JP3202607B2 (ja) *	1996-08-01	2001-08-27	帝人株式会社	２−（４−アルコキシ−３−シアノフェニル）チアゾール誘導体の製造法
US6225474B1 (en)	1998-06-19	2001-05-01	Teijin Limited	Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
DK1488790T3 (da)	2002-03-28	2014-10-13	Teijin Pharma Ltd	Fast præparat indeholdende en enkeltkrystalform A af etthiazolcarboxylsyrederivat

1999
- 1999-06-18 US US09/485,861 patent/US6225474B1/en not_active Expired - Lifetime
- 1999-06-18 SK SK220-2000A patent/SK287928B6/sk not_active IP Right Cessation
- 1999-06-18 ES ES08005933T patent/ES2718467T3/es not_active Expired - Lifetime
- 1999-06-18 HU HU0004325A patent/HU229405B1/hu active Protection Beyond IP Right Term
- 1999-06-18 IL IL13459499A patent/IL134594A/en not_active IP Right Cessation
- 1999-06-18 RU RU2000107108A patent/RU2198169C3/ru active
- 1999-06-18 EP EP08005933.0A patent/EP1956014B1/en not_active Revoked
- 1999-06-18 EP EP08005934.8A patent/EP1956015B2/en not_active Expired - Lifetime
- 1999-06-18 CN CN201010562692.0A patent/CN102020617B/zh not_active Expired - Lifetime
- 1999-06-18 UA UA2000031530A patent/UA57611C2/uk unknown
- 1999-06-18 ES ES99957054T patent/ES2336287T5/es not_active Expired - Lifetime
- 1999-06-18 CN CN2012101505038A patent/CN102659712A/zh active Pending
- 1999-06-18 PT PT99957054T patent/PT1020454E/pt unknown
- 1999-06-18 PT PT08005934T patent/PT1956015E/pt unknown
- 1999-06-18 CA CA002566652A patent/CA2566652C/en not_active Expired - Lifetime
- 1999-06-18 DK DK08005933.0T patent/DK1956014T3/da active
- 1999-06-18 LT LTEP08005933.0T patent/LT1956014T/lt unknown
- 1999-06-18 SI SI9931085T patent/SI1956014T1/sl unknown
- 1999-06-18 CA CA002301863A patent/CA2301863C/en not_active Expired - Lifetime
- 1999-06-18 EP EP99957054A patent/EP1020454B2/en not_active Expired - Lifetime
- 1999-06-18 KR KR10-2000-7001678A patent/KR100511183B1/ko active Protection Beyond IP Right Term
- 1999-06-18 DE DE69941672T patent/DE69941672D1/de not_active Expired - Lifetime
- 1999-06-18 SI SI9931037T patent/SI1020454T2/sl unknown
- 1999-06-18 ID IDW20000302D patent/ID25775A/id unknown
- 1999-06-18 DE DE122010000013C patent/DE122010000013I1/de active Pending
- 1999-06-18 AU AU42892/99A patent/AU748026B2/en not_active Expired
- 1999-06-18 JP JP2000554711A patent/JP3547707B2/ja not_active Expired - Lifetime
- 1999-06-18 TR TR2000/00458T patent/TR200000458T1/xx unknown
- 1999-06-18 IS IS9020A patent/IS9020A/is unknown
- 1999-06-18 SK SK5040-2010A patent/SK287946B6/sk not_active IP Right Cessation
- 1999-06-18 BR BR9906539-8A patent/BR9906539A/pt not_active Application Discontinuation
- 1999-06-18 WO PCT/JP1999/003258 patent/WO1999065885A1/ja active Application Filing
- 1999-06-18 PT PT80059330T patent/PT1956014T/pt unknown
- 1999-06-18 EP EP10185673.0A patent/EP2404910A3/en not_active Withdrawn
- 1999-06-18 HU HU1300546A patent/HU230799B1/hu unknown
- 1999-06-18 DK DK99957054.2T patent/DK1020454T4/da active
- 1999-06-18 NZ NZ503326A patent/NZ503326A/en not_active IP Right Cessation
- 1999-06-18 AT AT08005934T patent/ATE522512T2/de active
- 1999-06-18 CN CN99801366A patent/CN1275126A/zh active Pending
- 1999-06-18 PL PL338780A patent/PL200710B1/pl unknown
- 1999-06-18 CZ CZ20000582A patent/CZ298170B6/cs not_active IP Right Cessation
- 1999-06-18 SI SI9931060T patent/SI1956015T2/sl unknown
- 1999-06-18 DK DK08005934.8T patent/DK1956015T4/da active
- 1999-06-18 ES ES08005934T patent/ES2371786T5/es not_active Expired - Lifetime
- 1999-06-18 AT AT99957054T patent/ATE449765T1/de active
- 1999-12-16 TW TW088122172A patent/TWI248439B/zh not_active IP Right Cessation
- 1999-12-16 GT GT199900216A patent/GT199900216A/es unknown
2000
- 2000-02-15 ZA ZA200000737A patent/ZA200000737B/xx unknown
- 2000-02-16 IN IN9MU2000 patent/IN191537B/en unknown
- 2000-02-16 BG BG104159A patent/BG64734B1/bg unknown
- 2000-02-17 NO NO20000789A patent/NO321308B1/no not_active IP Right Cessation
- 2000-02-17 IS IS5377A patent/IS2886B/is unknown
- 2000-02-18 HR HR20000092A patent/HRP20000092C1/xx not_active IP Right Cessation
2001
- 2001-01-08 HK HK01100199.8A patent/HK1029788A1/xx not_active IP Right Cessation
2008
- 2008-11-12 HK HK08112377.0A patent/HK1118293A1/xx not_active IP Right Cessation
2010
- 2010-01-05 CY CY20101100014T patent/CY1109720T1/el unknown
- 2010-03-30 CY CY2010006C patent/CY2010006I1/el unknown
- 2010-04-12 FR FR10C0022C patent/FR10C0022I2/fr active Active
- 2010-04-22 LU LU91682C patent/LU91682I2/fr unknown
- 2010-05-12 BE BE2010C024C patent/BE2010C024I2/fr unknown
2011
- 2011-09-16 CY CY20111100901T patent/CY1111841T1/el unknown
2012
- 2012-03-07 HR HRP20120217AA patent/HRP20120217B1/hr not_active IP Right Cessation
2013
- 2013-01-25 IS IS9022A patent/IS9022A/is unknown
- 2013-01-25 IS IS9021A patent/IS3002B/is unknown

Also Published As

Publication number	Publication date
EP1956015B1 (en)	2011-08-31
SI1020454T1 (sl)	2010-02-26
ES2371786T3 (es)	2012-01-10
PT1956014T (pt)	2019-04-24
EP2404910A2 (en)	2012-01-11
ATE449765T1 (de)	2009-12-15
ID25775A (id)	2000-11-02
IS9020A (is)	2013-01-25
BR9906539A (pt)	2000-08-15
CZ298170B6 (cs)	2007-07-11
FR10C0022I1 (da)	2010-05-14
TWI248439B (en)	2006-02-01
CA2566652C (en)	2008-10-21
DK1020454T4 (da)	2013-11-25
HUP0004325A3 (en)	2001-12-28
HK1029788A1 (en)	2001-04-12
TR200000458T1 (tr)	2000-10-23
IS3002B (is)	2018-09-15
NO20000789L (no)	2000-02-17
SK2202000A3 (en)	2000-11-07
JP3547707B2 (ja)	2004-07-28
CY1109720T1 (el)	2012-01-25
EP1956014A2 (en)	2008-08-13
PL338780A1 (en)	2000-11-20
NZ503326A (en)	2002-02-01
RU2198169C2 (ru)	2003-02-10
SI1956015T1 (sl)	2011-10-28
US6225474B1 (en)	2001-05-01
EP1956014A3 (en)	2008-08-20
ES2371786T5 (es)	2019-04-22
SI1956014T1 (sl)	2019-02-28
SK287928B6 (sk)	2012-04-03
IN191537B (da)	2003-12-06
HRP20120217B1 (hr)	2019-04-05
CY1111841T1 (el)	2015-10-07
EP1020454B1 (en)	2009-11-25
IS9022A (is)	2013-01-25
HRPK20000092B1 (en)	2001-10-31
PT1020454E (pt)	2009-12-21
CY2010006I2 (el)	2012-01-25
NO321308B1 (no)	2006-04-24
IL134594A (en)	2004-12-15
EP1020454A4 (en)	2002-05-15
UA57611C2 (uk)	2003-06-16
CA2301863A1 (en)	1999-12-23
DK1956015T4 (da)	2019-02-11
RU2198169C3 (ru)	2017-07-20
IS5377A (is)	2000-02-17
HRP20000092C1 (en)	2012-04-30
ES2336287T5 (es)	2013-04-02
CN102020617B (zh)	2019-04-23
SI1956015T2 (sl)	2018-12-31
HUP0004325A2 (hu)	2001-10-28
ES2718467T3 (es)	2019-07-02
SI1020454T2 (sl)	2013-03-29
CN1275126A (zh)	2000-11-29
IS2886B (is)	2014-07-15
SK287946B6 (sk)	2012-06-04
WO1999065885A1 (en)	1999-12-23
DE122010000013I1 (de)	2010-07-08
IL134594A0 (en)	2001-04-30
CA2301863C (en)	2009-01-27
BG64734B1 (bg)	2006-01-31
LU91682I2 (fr)	2010-06-22
CY2010006I1 (el)	2012-01-25
NO20000789D0 (no)	2000-02-17
FR10C0022I2 (fr)	2013-08-16
DK1956014T3 (da)	2019-04-15
BG104159A (en)	2000-08-31
EP1020454A1 (en)	2000-07-19
CN102659712A (zh)	2012-09-12
PL200710B1 (pl)	2009-01-30
EP2404910A3 (en)	2014-10-29
CN102020617A (zh)	2011-04-20
LT1956014T (lt)	2019-03-25
EP1956015A3 (en)	2008-09-17
EP1956015A2 (en)	2008-08-13
KR20010023061A (ko)	2001-03-26
BE2010C024I2 (en)	2018-08-24
ES2336287T3 (es)	2010-04-09
HK1118293A1 (da)	2009-02-06
AU748026B2 (en)	2002-05-30
CZ2000582A3 (cs)	2000-07-12
ZA200000737B (en)	2000-09-08
EP1020454B2 (en)	2013-01-23
HU229405B1 (en)	2013-12-30
HRP20120217A2 (hr)	2012-05-31
KR100511183B1 (ko)	2005-08-30
HU230799B1 (hu)	2018-06-28
DK1956015T3 (da)	2011-09-26
DE69941672D1 (de)	2010-01-07
EP1956014B1 (en)	2019-01-16
GT199900216A (es)	2001-06-08
AU4289299A (en)	2000-01-05
ATE522512T2 (de)	2011-09-15
EP1956015B2 (en)	2018-11-14
IS9021A (is)	2013-01-25
LU91682I9 (da)	2019-01-09
PT1956015E (pt)	2011-11-02
HRP20000092A2 (en)	2000-08-31
CA2566652A1 (en)	1999-12-23

Publication	Publication Date	Title
DK1020454T3 (da)	2010-01-04	Polymorfe former af 2-(3-cyano-4-isobutyloxyphenyl)-4-mehyl-5-thiazol-carboxylsyre og fremgangsmåde til fremstilling deraf
MY115512A (en)	2003-06-30	Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
ECSP993280A (es)	2001-07-27	Polimorfos de acido 2- (3- ciano -4 -isobutiloxi fenil) -4 -metil -5-tiazol carboxilico y metodo de produccion de los mismos
UY25863A1 (es)	2000-08-21	Polimorfos de acido 2-(3-ciano-4-isobutiloxi fenil)4-metil 5 - tiazol carboxilico y metodo de produccion de los mismos.
AR021668A1 (es)	2002-07-31	Polimorfos de acido 2-(3-ciano-4-isobutiloxi fenil)-4-metil-5-tiazol carboxilico y metodo de produccion de los mismos